General Information
Revision date
2017-12-10
Product name
Atovaquone Oral Suspension, USP (750 mg/5 mL)
Product Synonyms
Active ingredient - Atovaquone; trans-2-[4-(4-Chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthalenedione
1.2.1 Relevant identified uses
Atovaquone Oral Suspension, USP is indicated in the prevention of Pneumocystis jiroveci pneumonia (PCP) in adults and adolescents aged 13 years and older who cannot tolerate trimethoprim-sulfamethoxazole (TMP-SMX), and for the treatment of mild-to-moderate PCP in adults and adolescents aged 13 years and older who cannot tolerate TMP-SMX
1.2.2. Uses advised against
Refer to the product insert and/or prescribing information for restrictions on use and contraindications
Icons in SDS
Company Information
company name
VistaPharm, Inc
Section 2
SECTION 2: Hazards identification
OSHA Classification of substance or mixture Product definition: Mixture
2.2 Label elements
Not a dangerous substance according to GHS
2.1 Classification of the substance or mixture
Product definition: Mixture Classification in accordance with 29 CFR 1910 (OSHA HCS) and Regulation (EC) No 1272/2008 Not a dangerous substance according to OSHA or to European Union Legislation